Valeant files annual report, says in compliance with covenants
April 29, 2016 at 07:54 AM EDT
(Reuters) - Beleaguered Canadian drugmaker Valeant Pharmaceuticals International Inc filed its annual report on Friday, which will help it stave of a default on its $30 billion debt.
